Does INGENOL MEBUTATE Cause Application site exfoliation? 586 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 586 reports of Application site exfoliation have been filed in association with INGENOL MEBUTATE. This represents 19.4% of all adverse event reports for INGENOL MEBUTATE.
586
Reports of Application site exfoliation with INGENOL MEBUTATE
19.4%
of all INGENOL MEBUTATE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Application site exfoliation From INGENOL MEBUTATE?
Of the 586 reports, 4 (0.7%) required hospitalization.
Is Application site exfoliation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 586 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site vesicles (843)
Drug administered at inappropriate site (500)
Application site swelling (489)
Application site scab (451)
Application site dryness (365)
Incorrect drug administration duration (339)
Application site pruritus (291)
Inappropriate schedule of drug administration (250)
What Other Drugs Cause Application site exfoliation?
MINOXIDIL (792)
SUMATRIPTAN (322)
BUPRENORPHINE (143)
DICLOFENAC (109)
PICATO (89)
TRETINOIN (75)
NICOTINE (69)
ESTRADIOL (62)
FENTANYL (59)
TAVABOROLE (56)
Which INGENOL MEBUTATE Alternatives Have Lower Application site exfoliation Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART